Edgewise Therapeutics price target raised to $52 from $50 at Leerink Partners
bullish
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
bullish
What happened, with direct paths to the underlying reporting
Leerink Partners raises EWTX target to $52; current price $33.28; price change since signal +$2.01.
Target: $52
Posted price: $33.28
Analyst firm: Leerink Partners
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.